American Shared Hospital Srvcs (AMS) Financials
$1.42
As on 08-Sep-2026 16:00EDT
Market cap
$10 Mln
Revenue (TTM)
$30 Mln
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
30.41
|
28.08
|
28.34
|
21.33
|
19.75
|
17.63
|
|||||
|
Cost of Revenue
|
25.21
|
23.04
|
19.16
|
11.98
|
11.36
|
10.90
|
|||||
|
Gross Profit
|
5.20
|
5.04
|
9.19
|
9.34
|
8.38
|
6.73
|
|||||
|
Operating Expenses
|
7.76
|
7.06
|
11.99
|
9.07
|
5.95
|
5.38
|
|||||
|
Operating Profit (EBIT)
|
-2.56
|
-2.01
|
-2.81
|
0.27
|
2.43
|
1.35
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
-3.22
|
-3.22
|
1.24
|
0.70
|
2.52
|
0.95
|
|||||
|
Provision for Tax
|
0.08
|
-0.49
|
-0.30
|
0.43
|
0.96
|
0.27
|
|||||
|
Profit after Tax (Net Income)
|
-1.77
|
-1.55
|
2.19
|
0.61
|
1.33
|
0.19
|
|||||
|
Minority Interest
|
1.04
|
1.17
|
0.65
|
0.04
|
-0.23
|
-0.48
|
|||||
|
Consolidated Profit
|
-0.65
|
-1.55
|
2.19
|
0.61
|
1.33
|
0.19
|
Liabilities ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
23.11
|
24.03
|
25.18
|
22.62
|
21.63
|
19.89
|
|||||
|
Minority Interest
|
1.04
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
4.26
|
4.34
|
19.77
|
11.10
|
13.16
|
15.30
|
|||||
|
Current Liabilities
|
22.42
|
23.44
|
10.41
|
10.78
|
5.18
|
5.89
|
|||||
|
Total Liabilities
|
74.92
|
55.48
|
60.20
|
48.16
|
43.96
|
45.43
|
Assets ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
35.13
|
37.76
|
33.94
|
27.71
|
25.23
|
30.34
|
|||||
|
Current Assets
|
17.37
|
17.72
|
26.26
|
20.46
|
18.72
|
15.09
|
|||||
|
Total Assets
|
69.86
|
55.48
|
60.20
|
48.16
|
43.96
|
45.43
|
|||||
|
Total Debt*
|
20.52
|
22.61
|
23.23
|
17.64
|
14.32
|
17.47
|
|||||
|
Net Current Assets
|
--
|
-5.72
|
15.85
|
9.68
|
13.55
|
9.20
|
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
3.10
|
0.17
|
5.72
|
7.24
|
6.27
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-7.63
|
-7.11
|
-6.27
|
-0.39
|
-1.67
|
|||||
|
Cash from Financing Activities
|
--
|
-3.03
|
4.41
|
1.91
|
-2.66
|
-0.66
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-0.26
|
-0.23
|
0.34
|
0.09
|
0.21
|
0.03
|
|||||
|
Cash EPS ($)
|
--
|
0.62
|
1.30
|
0.87
|
0.97
|
0.84
|
|||||
|
Adjusted Book Value ($)
|
--
|
3.60
|
3.92
|
3.45
|
3.44
|
3.25
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
0.46
|
0.03
|
0.87
|
1.15
|
1.02
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
-0.68
|
-1.21
|
-0.08
|
1.09
|
0.75
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-3.27
|
4.93
|
1.60
|
3.62
|
0.55
|
|||||
|
ROE (%)
|
-3.12
|
-6.31
|
9.15
|
2.76
|
6.40
|
0.99
|
|||||
|
ROA (%)
|
-2.30
|
-2.69
|
4.03
|
1.32
|
2.97
|
0.44
|
|||||
|
EBIT Margin (%)
|
-7.56
|
-5.86
|
9.65
|
8.48
|
16.83
|
9.56
|
|||||
|
Net Margin (%)
|
-5.83
|
-5.53
|
7.71
|
2.86
|
6.73
|
1.10
|
|||||
|
Cash Profit Margin (%)
|
0.00
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
3.97
|
-0.01
|
0.33
|
0.08
|
0.12
|
-0.01
|
|||||
|
EBIT Growth (%)
|
-105.91
|
-160.16
|
51.33
|
-45.61
|
97.15
|
120.08
|
|||||
|
Net Profit Growth (%)
|
38.18
|
-171.04
|
258.36
|
-54.07
|
584.54
|
102.75
|
|||||
|
EPS Growth (%)
|
29.85
|
-1.68
|
2.66
|
-0.56
|
5.66
|
1.03
|
|||||
|
Book Value Growth (%)
|
-9.58
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
-9.08
|
9.37
|
25.56
|
13.86
|
74.73
|
|||||
|
Price / Book Value
|
0.41
|
0.59
|
0.81
|
0.69
|
0.85
|
0.73
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
7.21
|
8.17
|
3.67
|
2.80
|
2.41
|
3.42
|
|||||
|
Close Price ($)
|
--
|
2.11
|
3.19
|
2.38
|
2.93
|
2.37
|
|||||
|
High Price ($)
|
--
|
3.26
|
4.60
|
3.75
|
3.10
|
5.04
|
|||||
|
Low Price ($)
|
--
|
2.02
|
2.37
|
2.16
|
2.08
|
2.03
|
|||||
|
Market Cap ($ Cr)
|
9.51
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.94
|
0.92
|
0.78
|
0.66
|
0.88
|
|||||
|
Short term debt to equity ratio
|
0.71
|
0.76
|
0.17
|
0.29
|
0.09
|
0.14
|
|||||
|
Current Ratio
|
0.77
|
0.76
|
2.52
|
1.90
|
3.62
|
2.56
|
|||||
|
Quick Ratio
|
0.77
|
--
|
2.66
|
--
|
3.38
|
2.36
|
|||||
|
Interest Coverage
|
-2.17
|
-1.05
|
1.83
|
1.63
|
4.12
|
2.27
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
32.15
|
47.08
|
44.68
|
22.73
|
20.91
|
27.37
|
|||||
|
Asset Turnover
|
0.39
|
0.49
|
0.52
|
0.46
|
0.44
|
0.40
|
|||||
|
Receivable days
|
--
|
168.34
|
112.84
|
76.86
|
82.79
|
97.37
|
|||||
|
Inventory Days
|
--
|
-22.07
|
-26.54
|
37.95
|
38.87
|
25.76
|
|||||
|
Payable days
|
--
|
17.19
|
17.90
|
8.31
|
8.81
|
16.77
|
|||||
|
Cash Conversion Cycle
|
--
|
129.08
|
68.40
|
106.51
|
112.86
|
106.37
|